Advertisement
Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. (XENE) Stock Overview

Explore Xenon Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

XENE●NASDAQ
HealthcareBiotechnology
$52.99
$0.47(0.88%)
U.S. Market opens in 16h 8m
Advertisement

Xenon Pharmaceuticals Inc. (XENE)

Meyka AI Score

Z

Key Financials

Market Cap4.2B
P/E Ratio-12.13
EPS (TTM)$-4.70
ROE-0.49%
Fundamental Analysis

AI Price Forecasts

1 Month$57.11
3 Months$60.03
1 Year Target$47.18

XENE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Xenon Pharmaceuticals Inc. (XENE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $47.18.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.13 and a market capitalization of 4.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.88%
5-Day Change
-3.23%
1-Month Change
-7.68%
3-Month Change
23.09%
6-Month Change
18.79%
Year-to-Date (YTD) Change
18.23%
1-Year Change
73.97%
3-Year Change
34.15%
5-Year Change
185.66%
All-Time (Max) Change
404.67%

Contact Information

https://www.xenon-pharma.com
16044843300
3650 Gilmore Way, Burnaby, BC, V5G 4W8

Company Facts

316 Employees
IPO DateNov 5, 2014
CountryCA
Actively Trading

Frequently Asked Questions